| Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer A Sawant, J Deshane, J Jules, CM Lee, BA Harris, X Feng, ... Cancer research 73 (2), 672-682, 2013 | 190 | 2013 |
| Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells A Sawant, JA Hensel, D Chanda, BA Harris, GP Siegal, A Maheshwari, ... The Journal of Immunology 189 (9), 4258-4265, 2012 | 189 | 2012 |
| Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations T Ge, MR Irvin, A Patki, V Srinivasasainagendra, YF Lin, HK Tiwari, ... Genome Medicine 14 (1), 70, 2022 | 91 | 2022 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 69 | 2023 |
| Opportunity for genotype‐guided prescribing among adult patients in 11 US health systems JK Hicks, N El Rouby, HH Ong, JS Schildcrout, LB Ramsey, Y Shi, ... Clinical Pharmacology & Therapeutics 110 (1), 179-188, 2021 | 42 | 2021 |
| Prescribing prevalence of medications with potential genotype-guided dosing in pediatric patients LB Ramsey, HH Ong, JS Schildcrout, Y Shi, LA Tang, JK Hicks, ... JAMA network open 3 (12), e2029411-e2029411, 2020 | 42 | 2020 |
| Prostate cancer‐derived cathelicidin‐related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic … HR Cha, JH Lee, JA Hensel, AB Sawant, BH Davis, CM Lee, JS Deshane, ... The Prostate 76 (7), 624-636, 2016 | 42 | 2016 |
| Pharmacogenetic predictors of cannabidiol response and tolerability in treatment‐resistant epilepsy BH Davis, TM Beasley, M Amaral, JP Szaflarski, T Gaston, ... Clinical Pharmacology & Therapeutics 110 (5), 1368-1380, 2021 | 36 | 2021 |
| Translational pharmacogenomics: discovery, evidence synthesis and delivery of race‐conscious medicine BH Davis, NA Limdi Clinical Pharmacology & Therapeutics 110 (4), 909-925, 2021 | 26 | 2021 |
| Personalizing direct oral anticoagulant therapy for a diverse population: role of race, kidney function, drug interactions, and pharmacogenetics LE Thompson, BH Davis, R Narayan, B Goff, TM Brown, NA Limdi Clinical Pharmacology & Therapeutics 113 (3), 585-599, 2023 | 16 | 2023 |
| Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples BH Davis, G DeFrank, NA Limdi, S Harada Clinical and Translational Science 13 (2), 260-264, 2020 | 13 | 2020 |
| Evaluation of population‐level pharmacogenetic actionability in Alabama BH Davis, K Williams, D Absher, B Korf, NA Limdi Clinical and Translational Science 14 (6), 2327-2338, 2021 | 6 | 2021 |
| UAB CBD Study Group (includes all the investigators involved in the UAB EAP CBD program). Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment … BH Davis, TM Beasley, M Amaral, JP Szaflarski, T Gaston, ... Clin. Pharmacol. Ther. 110, 1368-1380, 2021 | 5 | 2021 |
| Validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations T Ge, A Patki, V Srinivasasainagendra, YF Lin, MR Irvin, HK Tiwari, ... medRxiv, 2021.09. 11.21263413, 2021 | 4 | 2021 |
| Risk factors affecting polygenic score performance across diverse cohorts D Hui, S Dudek, K Kiryluk, TL Walunas, IJ Kullo, WQ Wei, H Tiwari, ... eLife 12, RP88149, 2025 | 3 | 2025 |
| Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis JD Anderson, BH Davis, G Giang, A Jones, CR Lee, K Parker, H Searcy, ... Clinical and Translational Science 16 (4), 662-672, 2023 | 2 | 2023 |
| Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortality BH Davis, AK Boehme, SV Pamboukian, M Allon, JF George, C Dillon, ... ASAIO Journal 66 (3), 268-276, 2020 | 2 | 2020 |
| Single-versus multi-ancestry polygenic risk scores for CKD in black Americans AC Jones, A Patki, V Srinivasasainagendra, HK Tiwari, ND Armstrong, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 1 | 2024 |
| 338 The Alabama Genomic Health Initiative: Integrating Genomic Medicine into Primary Care NA Limdi, D Absher, I Asif, L Bateman, G Barsh, KM Bowling, GM Cooper, ... Journal of Clinical and Translational Science 7 (s1), 100-101, 2023 | 1 | 2023 |
| Risk factors for major hemorrhage among patients receiving dabigatran across the Spectrum of CKD not requiring dialysis therapy BH Davis, R Sangha, C Dillon, TM Brown, R Narayan, M Beasley, ... American Journal of Kidney Diseases 78 (1), 151-153, 2021 | 1 | 2021 |
